Besbes, S., & Billard, C. (2015). First MCL-1-selective BH3 mimetics as potential therapeutics for targeted treatment of cancer. Cell Death Dis.
Chicago Style CitationBesbes, S., i C. Billard. "First MCL-1-selective BH3 Mimetics As Potential Therapeutics for Targeted Treatment of Cancer." Cell Death Dis 2015.
Cita MLABesbes, S., i C. Billard. "First MCL-1-selective BH3 Mimetics As Potential Therapeutics for Targeted Treatment of Cancer." Cell Death Dis 2015.
Atenció: Aquestes cites poden no estar 100% correctes.